The emerging evidence for vitamin D-mediated regulation of apolipoprotein A-I synthesis

Nutrition Research

Volumn 31, Issue 11, 2011, Pages 805-812

  Jaimungal, Sarada ^a   Wehmeier, Kent ^a   Mooradian, Arshag D ^a   Haas, Michael J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Apolipoprotein A I; Cardiovascular disease; HDLc; Vitamin D

Indexed keywords

APOLIPOPROTEIN A1; CALCIFEDIOL; CALCITRIOL; CALCIUM; CALCIUM LACTATE; COLECALCIFEROL; CYPROTERONE; ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; VITAMIN D;

ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; HORMONE SUBSTITUTION; HUMAN; INTERVENTION STUDY; LIPOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; REVIEW; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; AGED; ANIMALS; APOLIPOPROTEIN A-I; ATHEROSCLEROSIS; CALCIFEDIOL; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; CHOLECALCIFEROL; CHOLESTEROL, HDL; DIET; FEMALE; HUMANS; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, CALCITRIOL; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 82455181370     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2011.09.005     Document Type: Review

References (28)

1. Xu J., Kochanek K.D., Tejada-Vera B. Deaths: preliminary data for 2007. Natl Vital Stat Rep 2009, 58(1).
2. Pasternak R., Criqui M.H., Benjamin E.J., Fowkes G.R., Isselbacher E.M., McCullough P.A., et al. Atherosclerotic vascular disease conference writing group 1: epidemiology. Circulation 2004, 109:2605-2612.
3. Murray C.J., Lopez A.D. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997, 349:1269-1276.
4. Lopez A.D., Mathers C.D. Measuring the global burden of disease and epidemiology transitions: 2002-2030. Ann Trop Med Parasitol 2006, 100:481-499.
5. Badimon L., Vilahur G., Padro T. Lipoproteins, platelets and atherothrombosis. Rev EspCardiol 2009, 62:1161-1178.
6. Vanuzzo D., Pilotto L., Mipolo R., Pirelli S. Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation. G Ital Cardiol 2008, 9:6S-17S.
7. Hausenloy D.J., Yellon D.M. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels. Heart 2008, 94:706-714.
8. Gouni-Berthold I., Krone W., Berthold H.K. Vitamin D and cardiovascular disease. Curr Vasc Pharmol 2009, 7:414-422.
9. Artaza J.N., Mehrotra R., Norris K.C. Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol 2009, 4:1515-1522.
10. Dobnig H., Pilz S., Scharnagl H., Renner W., Seelhorst U., Wellnitz B., et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyviatmin D levels with all-cause mortality and cardiovascular mortality. Arch Intern Med 2008, 168:1340-1349.
11. Kim D.H., Sabour S., Sagar U.N., Adams S., Whellan D.J. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol 2008, 102:1540-1544.
12. Lee J.H., O'Keefe J.H., Bell D., Hensrud D.D., Holick M.F. Vitamin D deficiency and important, common, and easily treatable cardiovascular risk factor. J Am Coll Cardiol 2008, 52:1949-1956.
13. 3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. Eur J Endocrinol 1997, 137:495-502.
14. Johnson M.D., Nader N.S., Weaver A.L., Singh P., Kumar S. Relationships between 25-hydroxyvitamin D levels and plasma glucose and lipid levels in pediatric outpatients. J Pediatr 2010, 156:444-449.
15. John W.G., Noonan K., Mannan N., Boucher B. Hypovitaminosis D is associated with reductions in serum apolipoprotein A-1 but with fasting lipids in British Bangladeshis. Am J Clin Nutr 2005, 82:517-522.
16. Anderson R., Brot C., Mejborn H., Molgaard C., Skovgaard L.T., Trole E., et al. Vitamin D supplementation does not affect serum lipids and lipoproteins in Pakistani immigrants. Eur J Clin Nutr 2009, 63:1150-1153.
17. Devlin E.E., Lambert M., Levy E., O'Loughlin J., Mark S., Gray-Donald K., et al. Vitamin D status is modestly associated with glycemia and indicators of lipid metabolism in French-Canadian children and adolescents. J Nutr 2010, 149:987-991.
18. 3, apolipoprotein A-1, and high density lipoprotein cholesterol. Arterioscler Thromb 1992, 12:671-674.
19. Speeckaert M.M., Taes Y.E., De Buyzere M.L., Christophe A.B., Kaufman J., Delanghe J.R. Investigation of the potential association of vitamin D binding protein with lipoproteins. Ann Clin Biochem 2010, 47:143-150.
20. 3 for 1 year. J Intern Med 2010, 267:462-472.
21. Carbone L.D., Rosenberg E.W., Tolley E.A., Holick M.F., Hughes T.A., Watsky M.A., et al. 25-Hydroxyvitamin D, cholesterol, and ultraviolet radiation. Metabol 2008, 57:741-748.
22. Wang J., Keisala T., Solakivi T Minasyan A., Kalueff A.V., Tuohimaa P. Serum cholesterol and expression of ApoA1, LXRβ and SREBP2 in vitamin D receptor knockout mice. J Steroid Biochem Mol Biol 2009, 113:222-226.
23. 3. Biochim Biophys Acta 2005, 1737:16-26.
24. Vu-Dac N., Chopin-Delannoy S., Gervois P., Bennelye E., Martin G., Fruchart J.C., et al. The nuclear receptors peroxisome proliferator-activated receptor α and Rev-erbα mediate the species-specific regulation of apolipoprotein A-I expression by fibrates. J Biol Chem 1998, 273:25713-25720.
25. Haas M.J., Horani M., Mreyoud A., Plummer B., Wong N.C., Mooradian A.D. Suppression of apolipoprotein AI gene expression in HepG2 cells by TNF α and IL-1β. Biochim Biophys Acta 2003, 1623:120-128.
26. Wehmeier K.R., Mazza A., Hachem S., Ligaray K., Mooradian A.D., Wong N.C., et al. Differential regulation of apolipoprotein A-I gene expression by vitamin D receptor modulators. Biochim Biophys Acta 2008, 1780:264-273.
27. Boyan B.D., Sylvia V.L., Dean D.D., Schwartz Z. 24, 25-(OH)2D3 regulates cartilage and bone via autocrine and paracrine mechanisms. Steroids 2001, 66:363-374.
28. Wehmeier K.R., Alamir A., Sultan S., Haas M.J., Wong N.C.W., Mooradian A.D. 24,25- Dihhydroxycholecalciferol but not 25-hydroxycholecalciferol suppresses apolipoprotein A-I gene expression. Life Sci 2011, 88:110-116.